SOPHiA Genetics SA Current Cash

SOPHiA Genetics SA (SOPH) currently reports a current cash of $110M as of June 2026. That compares with $95M in the prior-year period — up 13.5% year over year. Use the charts on this page to explore SOPHiA Genetics SA's current cash history and peer comparisons.

SOPHiA Genetics SA's current cash increased from $95M to $110M — a 13.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

SOPHiA Genetics SA reported $110M in current cash as of June 2026. That compares with $95M in the prior-year period — up 13.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SOPHiA Genetics SA, and consider following SOPH for alerts when major investors trade the stock.

SOPHiA Genetics SA is classified in the Healthcare sector. On current cash, it currently shows $110M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SOPH with unrelated industries.